Express Delivery
All orders are shipped with Speedy
Cash on delivery
Reliable and convenient payment methods
Proven quality
Peptides Tested at Janoshik Labs
Express delivery in 1-3 business days.
Each peptide comes with bacteriostatic water.
GHRP-2 (Growth Hormone Releasing Peptide-2) is a synthetic hexapeptide that acts as an agonist of the ghrelin receptor GHS-R1a. Through this mechanism, it stimulates the pituitary gland to release growth hormone (GH) and is considered one of the early representatives of the GHRP family. In scientific literature, GHRP-2 has been discussed for its role in endogenous GH secretion, anabolic processes, tissue regeneration, and metabolic regulation.
Compared to GHRP-6, GHRP-2 is described as a more potent stimulator of GH pulses and a more selective representative of this group of peptides. In research models, effects on anabolism, lipolysis, bone health, appetite, and sleep quality have been observed. Due to its activity on ghrelin receptors, GHRP-2 is used as a model compound in studies on the GH/IGF-1 axis, regenerative processes, and energy balance.
GHRP-2 is being investigated for its potential effects on:
In scientific literature, subcutaneous administration in the range of 100-300 μg daily, typically divided into 1-3 applications within research protocols, has been described.
For 5 mg + 3 ml bacteriostatic water:
Concentration = 1.67 mg/ml → 0.15 ml = 250 μg
For 10 mg + 3 ml bacteriostatic water:
Concentration = 3.3 mg/ml → 0.15 ml = 500 μg
Example values for 5 mg:
0.06 ml = 100 μg
0.12 ml = 200 μg
0.18 ml = 300 μg
0.24 ml = 400 μg
Example values for 10 mg:
0.06 ml = 200 μg
0.12 ml = 400 μg
0.18 ml = 600 μg
0.24 ml = 800 μg
In scientific literature, GHRP-2 has been studied in both preclinical and clinical models. The peptide has been described to cause a dose-dependent increase in growth hormone (GH) and insulin-like growth factor-1 (IGF-1) through activation of GHS-R1a receptors, thereby stimulating endogenous GH release.
Among the representatives of the GHRP group, GHRP-2 stands out for its high efficacy and good stability, which makes it a subject of interest in fields such as endocrinology, gerontology, and sports medicine. Some publications note that at higher amounts, a moderate increase in cortisol and prolactin may be observed, highlighting the importance of controlled conditions in its experimental use.
GHRP-2 is prohibited by WADA for use in professional sports, as it can:
Adverse reactions described in scientific literature are usually dose-dependent and include:
Headache, dizziness, or transient discomfort are less commonly reported.
The information is collected and systematized from various scientific sources and studies. It serves educational purposes only and should not be used for the diagnosis, treatment, or prevention of diseases.